Cubist Systematic Strategies, LLC Reata Pharmaceuticals Inc Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$30.85 - $93.17 $852,292 - $2.57 Million	27,627 Added 377.47%	34,946 $3.18 Million
Q4 2022 Feb 14, 2023	SELL	$22.15 - $42.11 $533,039 - $1.01 Million	-24,065 Reduced 76.68%	7,319 $278,000
Q3 2022 Nov 14, 2022	BUY	$19.41 - $36.49 $233,017 - $438,062	12,005 Added 61.95%	31,384 $789,000
Q2 2022 Aug 15, 2022	SELL	$20.71 - $36.5 $182,455 - $321,565	-8,810 Reduced 31.25%	19,379 $589,000
Q1 2022 May 16, 2022	SELL	$24.12 - $39.6 $372,219 - $611,107	-15,432 Reduced 35.38%	28,189 $923,000
Q4 2021 Feb 14, 2022	BUY	$25.61 - $110.96 $304,400 - $1.32 Million	11,886 Added 37.45%	43,621 $1.15 Million
Q3 2021 Nov 15, 2021	BUY	$100.0 - $143.02 $1.17 Million - $1.68 Million	11,713 Added 58.5%	31,735 $3.19 Million
Q2 2021 Aug 16, 2021	SELL	$78.27 - $151.29 $1.2 Million - $2.31 Million	-15,295 Reduced 43.31%	20,022 $2.83 Million
Q1 2021 May 17, 2021	BUY	$94.25 - $132.81 $2.11 Million - $2.98 Million	22,410 Added 173.63%	35,317 $3.52 Million
Q4 2020 Feb 16, 2021	BUY	$102.03 - $184.62 $306,498 - $554,598	3,004 Added 30.33%	12,907 $1.6 Million
Q3 2020 Nov 16, 2020	SELL	$93.53 - $163.34 $383,379 - $669,530	-4,099 Reduced 29.27%	9,903 $965,000
Q2 2020 Aug 14, 2020	BUY	$126.3 - $176.56 $1.68 Million - $2.34 Million	13,267 Added 1805.03%	14,002 $2.19 Million
Q1 2020 May 15, 2020	SELL	$124.16 - $247.74 $179,783 - $358,727	-1,448 Reduced 66.33%	735 $106,000
Q4 2019 Feb 14, 2020	BUY	$74.57 - $217.92 $36,017 - $105,255	483 Added 28.41%	2,183 $446,000
Q3 2019 Nov 14, 2019	BUY	$71.26 - $95.75 $92,638 - $124,475	1,300 Added 325.0%	1,700 $136,000
Q2 2019 Aug 14, 2019	SELL	$77.72 - $94.35 $77,720 - $94,350	-1,000 Reduced 71.43%	400 $38,000
Q1 2019 May 15, 2019	SELL	$51.9 - $101.79 $690,840 - $1.35 Million	-13,311 Reduced 90.48%	1,400 $120,000
Q4 2018 Feb 14, 2019	BUY	$48.76 - $76.44 $624,371 - $978,814	12,805 Added 671.83%	14,711 $825,000
Q3 2018 Nov 14, 2018	SELL	$35.64 - $92.06 $88,886 - $229,597	-2,494 Reduced 56.68%	1,906 $156,000
Q2 2018 Aug 14, 2018	BUY	$19.94 - $40.96 $87,736 - $180,224	4,400 New	4,400 $154,000

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account